Table 1.
The Relationship Between DNER Expression and the Clinicopathological Characteristics in HCC
| Expression of DNER | ||||
|---|---|---|---|---|
| Characteristics | n | Low | High | p |
| Age | 0.275 | |||
| <60 | 41 | 23 | 18 | |
| ≥60 | 43 | 19 | 24 | |
| Gender | 0.649 | |||
| Female | 30 | 14 | 16 | |
| Male | 54 | 28 | 26 | |
| Grade | 0.272 | |||
| G1+G2 | 47 | 21 | 26 | |
| G3+G4 | 37 | 21 | 16 | |
| Pathologic stage | 0.013* | |||
| I+II | 53 | 32 | 21 | |
| III+IV | 31 | 10 | 21 | |
| Pathologic-T | 0.059 | |||
| T1+T2 | 58 | 33 | 25 | |
| T3+T4 | 26 | 9 | 17 | |
| Pathologic-N | 0.202 | |||
| N0 | 78 | 41 | 37 | |
| N1 | 6 | 1 | 5 | |
| Pathologic-M | 0.012* | |||
| M0 | 77 | 42 | 35 | |
| M1 | 7 | 0 | 7 | |
*
p < 0.05.
DNER, Delta/Notch-like EGF-related receptor; HCC, hepatocellular carcinoma.